These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6669590)

  • 21. [Flurazepam (Dalmadorm, Roche)].
    Frolund F
    Ugeskr Laeger; 1974 Jul; 136(28):1590-1. PubMed ID: 4407775
    [No Abstract]   [Full Text] [Related]  

  • 22. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing barbiturates: drug substitution in general practice.
    Wells FO
    J R Coll Gen Pract; 1973 Mar; 23(128):164-7. PubMed ID: 4768140
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Dormicum sleeping pills in everyday practice.
    Török K
    Ther Hung; 1992; 40(4):166-8. PubMed ID: 1345023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the treatment of sleep disorders with Speda].
    Hirsch W; von Frankenberg H
    Ther Ggw; 1969 Mar; 108(3):411-2 passim. PubMed ID: 5771447
    [No Abstract]   [Full Text] [Related]  

  • 27. Problems in the use of long-acting hypnotics in older patients.
    Kramer M; Schoen LS
    J Clin Psychiatry; 1984 Apr; 45(4):176-7. PubMed ID: 6715292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzodiazepine utilization in a family medicine residency program.
    Seifert RD; Clarens RD; Sorensen MD; Kuzel RJ; Lindblom ML
    J Fam Pract; 1982 Sep; 15(3):497-500. PubMed ID: 7108464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predicting the success of a benzodiazepine discontinuation programme: myths or clinical wisdom?].
    Knoop H; Kan CC; Mickers FC; Barnhoorn D
    Tijdschr Psychiatr; 2006; 48(9):695-703. PubMed ID: 17007475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The absence of benzodiazepine craving in a general practice benzodiazepine discontinuation trial.
    Mol AJ; Oude Voshaar RC; Gorgels WJ; Breteler MH; van Balkom AJ; van de Lisdonk EH; Kan CC; Mulder J; Zitman FG
    Addict Behav; 2006 Feb; 31(2):211-22. PubMed ID: 15951127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barbiturate therapy for patients with refractory intracranial hypertension following severe traumatic brain injury: its effects on tissue oxygenation, brain temperature and autoregulation.
    Thorat JD; Wang EC; Lee KK; Seow WT; Ng I
    J Clin Neurosci; 2008 Feb; 15(2):143-8. PubMed ID: 17997313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barbiturate-induced coma to protect against cerebral ischemia and increased intracranial pressure.
    Pappas TN; Mironovich RO
    Am J Hosp Pharm; 1981 Apr; 38(4):494-8. PubMed ID: 7025614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of drug dependence and abuse posed by barbiturate-containing analgesics.
    Sellers EM; Hoornweg K; Busto UE; Romach MK
    Can J Clin Pharmacol; 1999; 6(1):18-25. PubMed ID: 10465862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flurazepam toxicosis in two dogs.
    Beier E; Bischoff K
    Vet Hum Toxicol; 1997 Dec; 39(6):352-4. PubMed ID: 9397505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is there still room for barbiturates as hypnotics].
    Wesseling H
    Ned Tijdschr Geneeskd; 1977 Jan; 121(1):21-5. PubMed ID: 834324
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
    Blin O; Micallef J; Audebert C; Legangneux E
    J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of a non-barbiturate hypnotic "FH 040-3" (mepronizine) in a psychiatric setting].
    Subra G; Noyer J; Legros P
    Encephale; 1967; 56(5):469-79. PubMed ID: 4873379
    [No Abstract]   [Full Text] [Related]  

  • 39. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analgesic abuse and the barbiturate abstinence syndrome.
    Preskorn SH; Schwin RL; McKnelly WV
    JAMA; 1980 Jul; 244(4):369-70. PubMed ID: 7392132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.